SCHEMBL3407211

SCHEMBL3407211

NS(=O)(=O)c1ccc(C2CC2)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 10/20 0.43
CA2 P00918 10/20 0.43
CA6 P23280 9/20 0.43
CA7 P43166 9/20 0.43
CA5B Q9Y2D0 9/20 0.43
CA12 O43570 8/20 0.43
CA4 P22748 8/20 0.43
CA9 Q16790 8/20 0.43
CA14 Q9ULX7 8/20 0.43
CA3 P07451 7/20 0.43
CA5A P35218 5/20 0.43
SLC6A2 P23975 5/20 0.39
SLC6A4 P31645 5/20 0.39
SLC6A3 Q01959 4/20 0.39
CA13 Q8N1Q1 7/20 0.39
CISD1 Q9NZ45 2/20 0.39
LMNA P02545 1/20 0.38
CYP2C9 P11712 1/20 0.38
POLB P06746 1/20 0.38
APEX1 P27695 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2925439 0.84 TRPV4 (0.47) SLC6A2SLC6A4SLC6A3LMNAWDR5
SCHEMBL6951702 0.76 CYP2C8 (0.41) SLC6A2SLC6A4SLC6A3LMNAL3MBTL1
SCHEMBL962913 0.72 CA1 (0.53) CA1CA2CA6CA7CA5B
SCHEMBL29587590 0.72 CA1 (0.53) CA1CA2CA6CA7CA5B
SCHEMBL7952462 0.72 PTGS2 (0.51) CA1CA2CA6CA7CA5B
SCHEMBL939487 0.72 MMP2 (0.62) CA1CA2CA6CA7CA5B
SCHEMBL9870878 0.72 SLC6A2 (0.58) SLC6A2SLC6A4SLC6A3
SCHEMBL2954709 0.71 WDR5 (0.40) LMNAWDR5
SCHEMBL24313730 0.71 CA12 (0.54) CA1CA2CA12CA4CA9
SCHEMBL29587540 0.71 CA12 (0.54) CA1CA2CA12CA4CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2231595-B1 PHENYL ACETIC ACID DERIVATIVES AS INFLAMMATION MODULATORS AMGEN INC (US) 2014-04-23 EP disclosed
US-8183293-B2 Phenyl acetic acid derivatives AMGEN INC. (US) 2012-05-22 US disclosed
US-8183293-B2 Phenyl acetic acid derivatives AMGEN INC. (US) 2012-05-22 US disclosed
US-8183293-B2 Phenyl acetic acid derivatives AMGEN INC. (US) 2012-05-22 US disclosed
EP-2231595-A1 PHENYL ACETIC ACID DERIVATIVES AS INFLAMMATION MODULATORS Amgen, Inc (US) 2010-09-29 EP disclosed
US-20090275659-A1 Phenyl acetic acid derivatives as inflammation modulators AMGEN INC. (US) 2009-11-05 US disclosed
US-20090275659-A1 Phenyl acetic acid derivatives as inflammation modulators AMGEN INC. (US) 2009-11-05 US disclosed
US-20090275659-A1 Phenyl acetic acid derivatives as inflammation modulators AMGEN INC. (US) 2009-11-05 US disclosed
WO-2009085177-A1 PHENYL ACETIC ACID DERIVATIVES AS INFLAMMATION MODULATORS AMGEN INC. (US) 2009-07-09 WO disclosed
WO-2009085177-A1 PHENYL ACETIC ACID DERIVATIVES AS INFLAMMATION MODULATORS AMGEN INC. (US) 2009-07-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275659-A1 Phenyl acetic acid derivatives as inflammation modulators NFKBIA, HCAR2, NFATC1 CA1 1730/4885CA2 1159/4885CA6 747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.